Is headache a risk factor for dementia? A systematic review and meta-analysis.

Alzheimer’s disease Association Dementia Migraine Primary headaches

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
18 Sep 2023
Historique:
received: 11 04 2023
accepted: 09 09 2023
medline: 18 9 2023
pubmed: 18 9 2023
entrez: 18 9 2023
Statut: aheadofprint

Résumé

In this systematic review and meta-analysis, we critically evaluate available evidence regarding the association between primary headaches and subsequent decline of cognitive function and dementia. Recent studies suggested that headache disorders may increase the risk for dementia. However, available studies are conflicting. To identify qualifying studies, we searched scientific databases, including Pubmed, Scopus, Web of Science, Science Direct and BMC, screening for relevant papers. In order to reduce the heterogeneity between different studies, the analyses were further subdivided according to the clinical diagnoses and the study methodologies. We identified 23 studies investigating the association between primary headaches and the risk of dementia. Of these, 18 met our inclusion criteria for meta-analysis (covering 924.140 individuals). Overall effect-size shows that primary headaches were associated with a small increase in dementia risk (OR = 1,15; CI 95%: 1,03-1,28; p = 0,02). Analyzing subgroups, we found that migraine was associated with both a moderate increased risk of all-cause dementia (OR = 1,26; p = 0,00; 95% CI: 1,13-1,40) as well as a moderate increased risk of Alzheimer's disease (OR = 2,00; p = 0,00; 95% CI: 1,46-2,75). This association was significant in both case-control and retrospective cohort studies but not in prospective studies. Our study supports the presence of a link between primary headaches and dementia. However, in the subgroup analysis, only patients with migraine showed a moderate increase risk for all-cause dementia and for Alzheimer's disease. Additional rigorous studies are needed to elucidate the possible role of primary headaches on the risk of developing cognitive impairment and dementia.

Sections du résumé

OBJECTIVE OBJECTIVE
In this systematic review and meta-analysis, we critically evaluate available evidence regarding the association between primary headaches and subsequent decline of cognitive function and dementia.
BACKGROUND BACKGROUND
Recent studies suggested that headache disorders may increase the risk for dementia. However, available studies are conflicting.
METHODS METHODS
To identify qualifying studies, we searched scientific databases, including Pubmed, Scopus, Web of Science, Science Direct and BMC, screening for relevant papers. In order to reduce the heterogeneity between different studies, the analyses were further subdivided according to the clinical diagnoses and the study methodologies.
RESULTS RESULTS
We identified 23 studies investigating the association between primary headaches and the risk of dementia. Of these, 18 met our inclusion criteria for meta-analysis (covering 924.140 individuals). Overall effect-size shows that primary headaches were associated with a small increase in dementia risk (OR = 1,15; CI 95%: 1,03-1,28; p = 0,02). Analyzing subgroups, we found that migraine was associated with both a moderate increased risk of all-cause dementia (OR = 1,26; p = 0,00; 95% CI: 1,13-1,40) as well as a moderate increased risk of Alzheimer's disease (OR = 2,00; p = 0,00; 95% CI: 1,46-2,75). This association was significant in both case-control and retrospective cohort studies but not in prospective studies.
CONCLUSIONS CONCLUSIONS
Our study supports the presence of a link between primary headaches and dementia. However, in the subgroup analysis, only patients with migraine showed a moderate increase risk for all-cause dementia and for Alzheimer's disease. Additional rigorous studies are needed to elucidate the possible role of primary headaches on the risk of developing cognitive impairment and dementia.

Identifiants

pubmed: 37721571
doi: 10.1007/s10072-023-07069-0
pii: 10.1007/s10072-023-07069-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s).

Références

Wu YT et al (2017) The changing prevalence and incidence of dementia over time - current evidence. Nat Rev Neurol 13(6):327–339. https://doi.org/10.1038/nrneurol.2017.63
doi: 10.1038/nrneurol.2017.63 pubmed: 28497805
Aranda MP et al (2021) Impact of dementia: Health disparities, population trends, care interventions, and economic costs. J Am Geriatr Soc 69(7):1774–1783. https://doi.org/10.1111/jgs.17345
doi: 10.1111/jgs.17345 pubmed: 34245588 pmcid: 8608182
Vaupel JW, Villavicencio F, Bergeron-Boucher MP (2021) Demographic perspectives on the rise of longevity. Proc Natl Acad Sci U S A, 118(9). https://doi.org/10.1073/pnas.2019536118
Gale SA, Acar D, Daffner KR (2018) Dementia. Am J Med 131(10):1161–1169. https://doi.org/10.1016/j.amjmed.2018.01.022
doi: 10.1016/j.amjmed.2018.01.022 pubmed: 29425707
(2021) 2021 Alzheimer's disease facts and figures. Alzheimers Dement, 17(3):327–406. https://doi.org/10.1002/alz.12328
Robinson JL et al (2021) The development and convergence of co-pathologies in Alzheimer’s disease. Brain 144(3):953–962. https://doi.org/10.1093/brain/awaa438
doi: 10.1093/brain/awaa438 pubmed: 33449993 pmcid: 8041349
Montine TJ et al (2014) Recommendations of the Alzheimer’s disease-related dementias conference. Neurology 83(9):851–860. https://doi.org/10.1212/wnl.0000000000000733
doi: 10.1212/wnl.0000000000000733 pubmed: 25080517 pmcid: 4155046
Nianogo RA et al (2022) Risk Factors Associated With Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US. JAMA Neurol 79(6):584–591. https://doi.org/10.1001/jamaneurol.2022.0976
doi: 10.1001/jamaneurol.2022.0976 pubmed: 35532912 pmcid: 9086930
Omura JD et al (2022) Modifiable risk factors for Alzheimer disease and related dementias among adults aged ≥45 years - United States, 2019. MMWR Morb Mortal Wkly Rep 71(20):680–685
doi: 10.15585/mmwr.mm7120a2 pubmed: 35587456 pmcid: 9129905
Baumgart M et al (2015) Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement 11(6):718–726. https://doi.org/10.1016/j.jalz.2015.05.016
doi: 10.1016/j.jalz.2015.05.016 pubmed: 26045020
Killin LO et al (2016) Environmental risk factors for dementia: a systematic review. BMC Geriatr 16(1):175. https://doi.org/10.1186/s12877-016-0342-y
doi: 10.1186/s12877-016-0342-y pubmed: 27729011 pmcid: 5059894
Mier RW, Dhadwal S (2018) Primary headaches. Dent Clin North Am 62(4):611–628. https://doi.org/10.1016/j.cden.2018.06.006
doi: 10.1016/j.cden.2018.06.006 pubmed: 30189986
Martin PR (2020) Triggers of primary headaches: issues and pathways forward. Headache 60(10):2495–2507. https://doi.org/10.1111/head.13901
doi: 10.1111/head.13901 pubmed: 32648597
Wang J et al (2018) Headache disorder and the risk of dementia: a systematic review and meta-analysis of cohort studies. J Headache Pain 19(1):95. https://doi.org/10.1186/s10194-018-0925-4
doi: 10.1186/s10194-018-0925-4 pubmed: 30306350 pmcid: 6755577
Jiang W et al (2022) Migraine and the risk of dementia: a meta-analysis and systematic review. Aging Clin Exp Res 34(6):1237–1246. https://doi.org/10.1007/s40520-021-02065-w
doi: 10.1007/s40520-021-02065-w pubmed: 35102514
Wang L et al (2022) Meta-analysis of association between migraine and risk of dementia. Acta Neurol Scand 145(1):87–93. https://doi.org/10.1111/ane.13528
doi: 10.1111/ane.13528 pubmed: 34523724
Gu L, Wang Y, Shu H (2022) Association between migraine and cognitive impairment. J Headache Pain 23(1):88. https://doi.org/10.1186/s10194-022-01462-4
doi: 10.1186/s10194-022-01462-4 pubmed: 35883043 pmcid: 9317452
Mahmoud AN et al (2018) Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 8(3):e020498. https://doi.org/10.1136/bmjopen-2017-020498
doi: 10.1136/bmjopen-2017-020498 pubmed: 29593023 pmcid: 5875642
Magalhães JE, Sampaio Rocha-Filho PA (2018) Migraine and cerebrovascular diseases: Epidemiology, pathophysiological, and clinical considerations. Headache 58(8):1277–1286. https://doi.org/10.1111/head.13378
doi: 10.1111/head.13378 pubmed: 30117565
Devianne J et al (2022) Is there a link between headache and cognitive disorders? A systematic review. Rev Neurol (Paris) 178(4):285–290. https://doi.org/10.1016/j.neurol.2021.07.023
doi: 10.1016/j.neurol.2021.07.023 pubmed: 34689981
Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj 372:n71. https://doi.org/10.1136/bmj.n71
doi: 10.1136/bmj.n71 pubmed: 33782057 pmcid: 8005924
Wells GA, Shea B, O’Connell D et al (2008) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Chuang CS et al (2013) Migraine and risk of dementia: a nationwide retrospective cohort study. Neuroepidemiology 41(3–4):139–145. https://doi.org/10.1159/000353559
doi: 10.1159/000353559 pubmed: 23921376
Dewey ME, Davidson IA, Copeland JRM (1988) Risk factors for dementia: Evidence from the liverpool study of continuing health in the community. Int J Geriatr Psychiatry 3(4):245–249. https://doi.org/10.1002/gps.930030403
doi: 10.1002/gps.930030403
Echiverri K, Jicha GA, Smith JH (2018) Age-related changes in headache days across the cognitive spectrum. Pain Med 19(7):1478–1484. https://doi.org/10.1093/pm/pnx193
doi: 10.1093/pm/pnx193 pubmed: 29024962
George KM et al (2020) Migraine headache and risk of dementia in the atherosclerosis risk in communities neurocognitive study. Headache 60(5):946–953. https://doi.org/10.1111/head.13794
doi: 10.1111/head.13794 pubmed: 32200562 pmcid: 7192135
Hagen K et al (2014) Headache as a risk factor for dementia: a prospective population-based study. Cephalalgia 34(5):327–335. https://doi.org/10.1177/0333102413513181
doi: 10.1177/0333102413513181 pubmed: 24265286
Hurh K et al (2022) Increased risk of all-cause, Alzheimer’s, and vascular dementia in adults with migraine in Korea: a population-based cohort study. J Headache Pain 23(1):108. https://doi.org/10.1186/s10194-022-01484-y
doi: 10.1186/s10194-022-01484-y pubmed: 36002812 pmcid: 9404580
Islamoska S et al (2020) Mid- to late-life migraine diagnoses and risk of dementia: a national register-based follow-up study. J Headache Pain 21(1):98. https://doi.org/10.1186/s10194-020-01166-7
doi: 10.1186/s10194-020-01166-7 pubmed: 32762715 pmcid: 7410151
Kim SJ et al (2022) Primary headaches increase the risk of dementias: An 8-year nationwide cohort study. PLoS One 17(8):e0273220. https://doi.org/10.1371/journal.pone.0273220
doi: 10.1371/journal.pone.0273220 pubmed: 35980951 pmcid: 9387842
Kostev K, Bohlken J, Jacob L (2019) Association between migraine headaches and dementia in more than 7,400 patients followed in general practices in the United Kingdom. J Alzheimers Dis 71(1):353–360. https://doi.org/10.3233/jad-190581
doi: 10.3233/jad-190581 pubmed: 31403950
Lee SY et al (2019) Increased risk of neurodegenerative dementia in women with migraines: A nested case-control study using a national sample cohort. Medicine (Baltimore) 98(7):e14467. https://doi.org/10.1097/md.0000000000014467
doi: 10.1097/md.0000000000014467 pubmed: 30762763
Lee HJ et al (2021) Mid- and late-life migraine is associated with an increased risk of all-cause dementia and Alzheimer's disease, but Not vascular dementia: A nationwide retrospective cohort study. J Pers Med 11(10). https://doi.org/10.3390/jpm11100990
Liang Y et al (2022) Migraine, cognitive decline, and dementia in older adults: A population-based study. J Alzheimers Dis 88(1):263–271. https://doi.org/10.3233/jad-220013
doi: 10.3233/jad-220013 pubmed: 35570487
Lin PC et al (2018) Prevalence of pain-related diagnoses in patients with dementia: a nationwide study. J Pain Res 11:1589–1598. https://doi.org/10.2147/jpr.S172875
doi: 10.2147/jpr.S172875 pubmed: 30214270 pmcid: 6126483
Martins IP et al (2020) Cognitive aging in migraine sufferers is associated with more subjective complaints but similar age-related decline: a 5-year longitudinal study. J Headache Pain 21(1):31. https://doi.org/10.1186/s10194-020-01100-x
doi: 10.1186/s10194-020-01100-x pubmed: 32264821 pmcid: 7137205
Morgan K, Lilley JM (1994) Risk factors among incident cases of dementia in a representative british sample. Int J Geriatr Psychiatry 9(1):11–15. https://doi.org/10.1002/gps.930090104
doi: 10.1002/gps.930090104
Morton RE, St John PD, Tyas SL (2019) Migraine and the risk of all-cause dementia, Alzheimer’s disease, and vascular dementia: A prospective cohort study in community-dwelling older adults. Int J Geriatr Psychiatry 34(11):1667–1676. https://doi.org/10.1002/gps.5180
doi: 10.1002/gps.5180 pubmed: 31486140
(2013) Abstracts of the 2013 International Headache Congress, 27–30 June 2013, John B. Hynes Veterans Memorial, Convention Center, Boston, MA, USA. Cephalalgia 33(8_suppl):1–309. https://doi.org/10.1177/0333102413490487
Recchia A et al (2016) P4–237: Headaches and dementia in the Oldest-Old: The Monzino 80-plus population-based study. Alzheimer’s Dementia 12(7S_Part_23):P1120–P1121. https://doi.org/10.1016/j.jalz.2016.06.2329
doi: 10.1016/j.jalz.2016.06.2329
Stræte Røttereng AK et al (2015) Headache as a predictor for dementia: The HUNT Study. J Headache Pain 16:89. https://doi.org/10.1186/s10194-015-0573-x
doi: 10.1186/s10194-015-0573-x pubmed: 26471177
Tyas SL et al (2001) Risk factors for Alzheimer’s disease: a population-based, longitudinal study in Manitoba. Canada Int J Epidemiol 30(3):590–597. https://doi.org/10.1093/ije/30.3.590
doi: 10.1093/ije/30.3.590 pubmed: 11416089
Tzeng NS et al (2017) Headaches and risk of dementia. Am J Med Sci 353(3):197–206. https://doi.org/10.1016/j.amjms.2016.12.014
doi: 10.1016/j.amjms.2016.12.014 pubmed: 28262204
Yang FC et al (2016) Increased Risk of dementia in patients with tension-type headache: A nationwide retrospective population-based cohort Study. PLoS One 11(6):e0156097. https://doi.org/10.1371/journal.pone.0156097
doi: 10.1371/journal.pone.0156097 pubmed: 27272332 pmcid: 4896423
Yin JH et al (2018) Age-specific and gender-dependent impact of primary headache disorders on dementia risk: Population-based longitudinal study. Medicine (Baltimore) 97(52):e13789. https://doi.org/10.1097/md.0000000000013789
doi: 10.1097/md.0000000000013789 pubmed: 30593163
Vassallo L et al (2022) The mysterious connection between migraine and dementia: epiphenomenon or causation? Special considerations. Aging Clin Exp Res 34(8):1947–1948. https://doi.org/10.1007/s40520-022-02169-x
doi: 10.1007/s40520-022-02169-x pubmed: 35750939
Chen SP, Ayata C (2016) Spreading depression in primary and secondary headache disorders. Curr Pain Headache Rep 20(7):44. https://doi.org/10.1007/s11916-016-0574-8
doi: 10.1007/s11916-016-0574-8 pubmed: 27215627
Botto R et al (2022) Anxiety and depression in Alzheimer’s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline. Neurol Sci 43(7):4107–4124. https://doi.org/10.1007/s10072-022-06068-x
doi: 10.1007/s10072-022-06068-x pubmed: 35461471 pmcid: 9213384
Ye Q, Bai F, Zhang Z (2016) Shared genetic risk factors for late-life depression and Alzheimer’s disease. J Alzheimers Dis 52(1):1–15. https://doi.org/10.3233/jad-151129
doi: 10.3233/jad-151129 pubmed: 27060956
Lopera F et al (1997) Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 277(10):793–799
doi: 10.1001/jama.1997.03540340027028 pubmed: 9052708
Campbell NL et al (2013) Risk factors for the progression of mild cognitive impairment to dementia. Clin Geriatr Med 29(4):873–893. https://doi.org/10.1016/j.cger.2013.07.009
doi: 10.1016/j.cger.2013.07.009 pubmed: 24094301 pmcid: 5915285
Lipnicki DM et al (2019) Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort study. PLoS Med 16(7):e1002853. https://doi.org/10.1371/journal.pmed.1002853
doi: 10.1371/journal.pmed.1002853 pubmed: 31335910 pmcid: 6650056
Del Moro L et al (2022) Migraine, brain glucose metabolism and the “Neuroenergetic” hypothesis: A scoping review. J Pain 23(8):1294–1317. https://doi.org/10.1016/j.jpain.2022.02.006
doi: 10.1016/j.jpain.2022.02.006 pubmed: 35296423
Griffith CM et al (2018) Evidence for altered insulin receptor signaling in Alzheimer’s disease. Neuropharmacology 136(Pt B):202–215. https://doi.org/10.1016/j.neuropharm.2018.01.008
doi: 10.1016/j.neuropharm.2018.01.008 pubmed: 29353052
Wang X et al (2014) Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta 8:1240–1247. https://doi.org/10.1016/j.bbadis.2013.10.015
doi: 10.1016/j.bbadis.2013.10.015
Ramachandran R et al (2019) Role of Toll-like receptor 4 signaling in mast cell-mediated migraine pain pathway. Mol Pain 15:1744806919867842. https://doi.org/10.1177/1744806919867842
doi: 10.1177/1744806919867842 pubmed: 31342858 pmcid: 6688145
(2018) Headache classification committee of the international headache society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1):1–211. https://doi.org/10.1177/0333102417738202
McKhann GM et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3):263–269. https://doi.org/10.1016/j.jalz.2011.03.005
doi: 10.1016/j.jalz.2011.03.005 pubmed: 21514250 pmcid: 3312024
Jack CR Jr et al (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement 14(4):535–562. https://doi.org/10.1016/j.jalz.2018.02.018
doi: 10.1016/j.jalz.2018.02.018 pubmed: 29653606 pmcid: 5958625

Auteurs

Aurora Cermelli (A)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.

Fausto Roveta (F)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.

Lia Giorgis (L)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.

Silvia Boschi (S)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.

Alberto Grassini (A)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.

Fabio Ferrandes (F)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.

Chiara Lombardo (C)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.

Andrea Marcinnò (A)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.

Elisa Rubino (E)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy.
Department of Neuroscience and Mental Health, Città della Salute e della Scienza, Corso Bramante 88, Turin, Italy.

Innocenzo Rainero (I)

Headache Center, Department of Neuroscience, ''Rita Levi Montalcini'', University of Torino, Via Cherasco 15, 10126, Turin, Italy. innocenzo.rainero@unito.it.
Department of Neuroscience and Mental Health, Città della Salute e della Scienza, Corso Bramante 88, Turin, Italy. innocenzo.rainero@unito.it.

Classifications MeSH